Diamedica Therapeutics Updates SEC Filing

Diamedica Therapeutics (DMAC) has released an update.

Diamedica Therapeutics Inc., a company incorporated in British Columbia, has filed a current report with the SEC on April 5, 2024, detailing updates to their corporate information. The report highlights the company’s principal executive offices in Minneapolis, Minnesota, and confirms Diamedica’s shares are traded on The Nasdaq Stock Market LLC under the trading symbol DMAC. Additionally, Diamedica Therapeutics has not identified itself as an emerging growth company in this filing.

For further insights into DMAC stock, check out TipRanks’ Stock Analysis page.